MS
Publicaties op Oncologisch.com
Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA resul...
Subcutaneous versus intravenous pembrolizumab, in combination with chemotherapy, for treatment of metastatic non-smal...
Avelumab versus chemotherapie als derdelijns bij maagcarcinoom: JAVELIN Gastric 300 fase III